Improved Escherichia coli bactofection and cytotoxicity by heterologous expression of bacteriophage φx174 lysis gene e

Molecular Pharmaceutics

Volumn 12, Issue 5, 2015, Pages 1691-1700

  Chung, Tai Chun ^a   Jones, Charles H ^a   Gollakota, Akhila ^a   Kamal Ahmadi, Mahmoud ^a   Rane, Snehal ^a   Zhang, Guojian ^a   Pfeifer, Blaine A ^a  

^a the State University of New York   (United States)

Author keywords

attenuation; bactofection; Escherichia coli; gene delivery; gene therapy

Indexed keywords

BACTERIAL VECTOR; BACTOFECTION VECTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; ATTENUATION; BACTERIAL STRAIN; BACTERIOPHAGE PHI X 174; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; ENGINEERING; ESCHERICHIA COLI; GENE; GENE TARGETING; GENE THERAPY; HETEROLOGOUS EXPRESSION; IMMUNE RESPONSE; IMMUNOMODULATION; LYSIS; MACROPHAGE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; ANIMAL; BACTERIOPHAGE; CELL LINE; GENE VECTOR; GENETICS; METABOLISM;

ANIMALS; BACTERIOPHAGES; CELL LINE; ESCHERICHIA COLI; GENETIC THERAPY; GENETIC VECTORS; MICE;

EID: 84929179387     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/acs.molpharmaceut.5b00172     Document Type: Article

References (29)

1. Jones, C. H.; Chen, C. K.; Ravikrishnan, A.; Rane, S.; Pfeifer, B. A. Overcoming nonviral gene delivery barriers: perspective and future Mol. Pharmaceutics 2013, 10, 4082-4098
2. Parsa, S.; Pfeifer, B. Engineering bacterial vectors for delivery of genes and proteins to antigen-presenting cells Mol. Pharmaceutics 2007, 4, 4-17
3. Jones, C. H.; Hakansson, A. P.; Pfeifer, B. A. Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design J. Mater. Chem. B 2014, 2, 8053-8068
4. Birmingham, C. L.; Canadien, V.; Kaniuk, N. A.; Steinberg, B. E.; Higgins, D. E.; Brumell, J. H. Listeriolysin O allows Listeria monocytogenes replication in macrophage vacuoles Nature 2008, 451, 350-354
5. Price, J. V.; Vance, R. E. The macrophage paradox Immunity 2014, 41, 685-693
6. Harb, O. S.; Gao, L. Y.; Abu Kwaik, Y. From protozoa to mammalian cells: a new paradigm in the life cycle of intracellular bacterial pathogens Environ. Microbiol. 2000, 2, 251-265
7. Higgins, D. E.; Shastri, N.; Portnoy, D. A. Delivery of protein to the cytosol of macrophages using Escherichia coli K-12 Mol. Microbiol. 1999, 31, 1631-1641
8. Parsa, S.; Wang, Y.; Rines, K.; Pfeifer, B. A. A high-throughput comparison of recombinant gene expression parameters for E. coli -mediated gene transfer to P388D1 macrophage cells J. Biotechnol. 2008, 137, 59-64
9. Parsa, S.; Wang, Y.; Fuller, J.; Langer, R.; Pfeifer, B. A. A comparison between polymeric microsphere and bacterial vectors for macrophage P388D1 gene delivery Pharm. Res. 2008, 25, 1202-1208
10. Jones, C. H.; Chen, C. K.; Chen, M.; Ravikrishnan, A.; Zhang, H.; Gollakota, A.; Chung, T.; Cheng, C.; Pfeifer, B. A. PEGylated cationic polylactides for hybrid biosynthetic gene delivery Mol. Pharmaceutics 2015, 12, 846-856
11. Jones, C. H.; Ravikrishnan, A.; Chen, M.; Reddinger, R.; Kamal Ahmadi, M.; Rane, S.; Hakansson, A. P.; Pfeifer, B. A. Hybrid biosynthetic gene therapy vector development and dual engineering capacity Proc. Natl. Acad. Sci. U.S.A. 2014, 111, 12360-12365
12. Jones, C. H.; Rane, S.; Patt, E.; Ravikrishnan, A.; Chen, C. K.; Cheng, C.; Pfeifer, B. A. Polymyxin B treatment improves bactofection efficacy and reduces cytotoxicity Mol. Pharmaceutics 2013, 10, 4301-4308
13. Medina, E.; Guzman, C. A. Use of live bacterial vaccine vectors for antigen delivery: potential and limitations Vaccine 2001, 19, 1573-80
14. Dietrich, G.; Spreng, S.; Favre, D.; Viret, J. F.; Guzman, C. A. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines Curr. Opin. Mol. Ther. 2003, 5, 10-19
15. Daudel, D.; Weidinger, G.; Spreng, S. Use of attenuated bacteria as delivery vectors for DNA vaccines Expert Rev. Vaccines 2007, 6, 97-110
16. Chart, H.; Smith, H. R.; La Ragione, R. M.; Woodward, M. J. An investigation into the pathogenic properties of Escherichia coli strains BLR, BL21, DH5alpha and EQ1 J. Appl. Microbiol. 2000, 89, 1048-1058
17. Katrukha, G. S.; Baratova, L. A.; Silaev, A. B. A study of the mechanism of polymyxin M inactivation Experientia 1968, 24, 540-541
18. Hsu Chen, C. C.; Feingold, D. S. The mechanism of polymyxin B action and selectivity toward biologic membranes Biochemistry 1973, 12, 2105-2111
19. Edberg, S. C.; Bottenbley, C. J.; Singer, J. M. The mechanism of inhibition of aminoglycoside and polymyxin class antibiotics by polyanionic detergents Proc. Soc. Exp. Biol. Med. 1976, 153, 49-51
20. Gilleland, H. E., Jr.; Farley, L. B. Adaptive resistance to polymyxin in Pseudomonas aeruginosa due to an outer membrane impermeability mechanism Can. J. Microbiol. 1982, 28, 830-840
21. Studier, F. W.; Moffatt, B. A. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes J. Mol. Biol. 1986, 189, 113-130
22. Geoffroy, C.; Gaillard, J. L.; Alouf, J. E.; Berche, P. Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes Infect. Immun. 1987, 55, 1641-1646
23. Radford, K. J.; Higgins, D. E.; Pasquini, S.; Cheadle, E. J.; Carta, L.; Jackson, A. M.; Lemoine, N. R.; Vassaux, G. A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy Gene Ther. 2002, 9, 1455-1463
24. Seow, Y.; Wood, M. J. Biological gene delivery vehicles: beyond viral vectors Mol. Ther. 2009, 17, 767-777
25. Critchley, R. J.; Jezzard, S.; Radford, K. J.; Goussard, S.; Lemoine, N. R.; Grillot-Courvalin, C.; Vassaux, G. Potential therapeutic applications of recombinant, invasive E. coli Gene Ther. 2004, 11, 1224-1233
26. Cheung, W.; Kotzamanis, G.; Abdulrazzak, H.; Goussard, S.; Kaname, T.; Kotsinas, A.; Gorgoulis, V. G.; Grillot-Courvalin, C.; Huxley, C. Bacterial delivery of large intact genomic-DNA-containing BACs into mammalian cells Bioeng. Bugs 2012, 3, 86-92
27. Larsen, M. D.; Griesenbach, U.; Goussard, S.; Gruenert, D. C.; Geddes, D. M.; Scheule, R. K.; Cheng, S. H.; Courvalin, P.; Grillot-Courvalin, C.; Alton, E. W. Bactofection of lung epithelial cells in vitro and in vivo using a genetically modified Escherichia coli Gene Ther. 2008, 15, 434-442
28. Grillot-Courvalin, C.; Goussard, S.; Courvalin, P. Wild-type intracellular bacteria deliver DNA into mammalian cells Cell. Microbiol.y 2002, 4, 177-186
29. Grillot-Courvalin, C.; Goussard, S.; Courvalin, P. Bacteria as gene delivery vectors for mammalian cells Curr. Opin. Biotechnol. 1999, 10, 477-481